World Psychiatry· Aaron Keshen,
Elena Koning,
Kelly C. Allison,
Anastassia Amaro,
Sara Bartel,
Pauline Belliveau,
Lisa Boniferro,
Simran Brar,
Sonia Butalia,
Cynthia M. Bulik,
Ariana M. Chao,
Jennifer Couturier,
Kimberly Dennis,
Laura Dixon,
Deena El‐Ziftawi,
Chloe Gao,
Susan Gamberg,
Anthony P. Goldstone,
Riccardo Dalle Grave,
Anna I. Guerdjikova,
Tanya M. Halliday,
Margaret Hahn,
Anastasia Harris,
Hubertus Himmerich,
William B. Horton,
Monique Jericho,
Brooke Langman,
Amanda Lightbody,
Diane A. Klein,
Laurel E.S. Mayer,
Susan L. McElroy,
Michael Mindrum,
Nicholas C. Peiper,
Colby Price,
Amanda Raffoul,
Jesse Richards,
Lauren M. Schaefer,
Joanna Steinglass,
Valerie H. Taylor,
Beverly G. Tchang,
Nami Trappenberg,
B. Timothy Walsh,
Michael A. Weintraub,
Ashley White,
Susan Wnuk·· 18 天前精选AI 评分62
改良德尔菲研究发布GLP-1受体激动剂用于进食障碍人群的临床与研究共识建议
Consensus‐based clinical and research recommendations for use of glucagon‐like peptide‐1 receptor agonists in the context of eating disorders: a modified Delphi study
AI 导读
一项改良三轮德尔菲研究由糖尿病、肥胖和进食障碍领域的多学科专家及有亲身经历者共45人参与，就GLP-1受体激动剂（GLP-1RAs）相关建议达成平均91.7%的共识。
推荐理由
围绕GLP-1受体激动剂在进食障碍人群中的使用，专家共识给出了筛查、监测与心理治疗并行的临床路径。
来源：World Psychiatry · onlinelibrary.wiley.com